Инфекционные болезни
1543 статей · 54 журналов
Журналы подкатегории (54)
- Clinical Infection in Practice · Elsevier (81)
- Clinical Microbiology and Infection · Elsevier (81)
- Journal of Hospital Infection · Elsevier (80)
- Journal of Migration and Health · Elsevier (80)
- The Lancet Infectious Diseases · Elsevier (79)
- IDCases · Elsevier (78)
- Infection Prevention in Practice · Elsevier (77)
- New Microbes and New Infections · Elsevier (75)
- Journal of Infection and Chemotherapy · Elsevier (69)
- Journal of Microbiology, Immunology and Infection · Elsevier (63)
- Tropical Medicine and International Health · Wiley (63)
- Acta Tropica · Elsevier (54)
- Indian Journal of Tuberculosis · Elsevier (52)
- Diagnostic Microbiology and Infectious Disease · Elsevier (49)
- Hepatology Research · Wiley (47)
- Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · Elsevier (43)
- Anaerobe · Elsevier (40)
- The Lancet HIV · Elsevier (40)
- Infection, Disease & Health · Elsevier (37)
- Microbial Risk Analysis · Elsevier (37)
- Journal of Clinical Virology · Elsevier (35)
- Ticks and Tick-borne Diseases · Elsevier (35)
- Biosafety and Health · Elsevier (31)
- Transplant Infectious Disease · Wiley (28)
- Travel Medicine and Infectious Disease · Elsevier (28)
- Journal of Medical Virology · Wiley (23)
- Infectious Diseases Now · Elsevier (21)
- Spatial and Spatio-temporal Epidemiology · Elsevier (19)
- Reviews in Medical Virology · Wiley (18)
- Vacunas · Elsevier (18)
- Zoonoses and Public Health · Wiley (18)
- Influenza and other Respiratory Viruses · Wiley (13)
- Clinical Microbiology Newsletter · Elsevier (8)
- The Brazilian Journal of Infectious Diseases · Elsevier (8)
- Mycoses · Wiley (7)
- Journal of the International AIDS Society · Wiley (5)
- Helicobacter · Wiley (3)
- AIDS and Behavior · Springer Nature (0)
- Annals of Clinical Microbiology and Antimicrobials · Springer Nature (0)
- BMC Infectious Diseases · Springer Nature (0)
- Current Fungal Infection Reports · Springer Nature (0)
- Current HIV/AIDS Reports · Springer Nature (0)
- Current Infectious Disease Reports · Springer Nature (0)
- Current Tropical Medicine Reports · Springer Nature (0)
- Gut Pathogens · Springer Nature (0)
- Hepatology Research · Springer Nature (0)
- Infection · Springer Nature (0)
- Journal of Ophthalmic Inflammation and Infection · Springer Nature (0)
- Malaria Journal · Springer Nature (0)
- Parasitology Research · Springer Nature (0)
- Retrovirology · Springer Nature (0)
- Tropical Diseases, Travel Medicine and Vaccines · Springer Nature (0)
- Tropical Medicine and Health · Springer Nature (0)
- Virology Journal · Springer Nature (0)
- Vasee Moorthy
- Size of the 2026 Ebola outbreak and risk of cross-border spillover from Bundibugyo virus in Ituri Province, DR Congo, and its implications for preparedness: a recalibrated stochastic modelling study
- Global, regional, and national burden of tuberculosis and multidrug-resistant tuberculosis by HIV status, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
- Community-based tuberculosis screening with computer-aided detection technology alone and in combination with point-of-care C-reactive protein testing: a paired screen-positive trial
- Community-engaged implementation strategies to increase doxycycline post-exposure prophylaxis uptake among men who have sex with men in China (DoxyForward): a three-group, open-label, randomised controlled trial
- Mapping the prevalence of molecular markers of Plasmodium falciparum artemisinin partial resistance in Africa: a systematic review and spatiotemporal modelling study
- Efficacy of WRSs2, a live-attenuated Shigella sonnei vaccine, against shigellosis in a controlled human infection model in the USA: a phase 2, double-blind, randomised, placebo-controlled trial
- Quantifying how multiple transmission routes contribute to the spread of HTLV-1 in different endemic foci: a mathematical modelling study
- Efficacy, safety, and immunogenicity of an Escherichia coli-produced nine-valent human papillomavirus vaccine: a multicentre, double-blind, randomised, controlled, phase 3 trial
- Guiding principles for pragmatic randomised trials of tuberculosis treatments
- Nucleic acid amplification testing and genome sequencing for WHO priority viruses in Africa: a scoping review
- Empiric tuberculosis treatment in hospitalised adults with advanced HIV disease in Africa: applying the therapeutic threshold to clinical practice
- A fatal case of Legionella micdadei prosthetic valve endocarditis diagnosed by plasma microbial cell-free DNA metagenomic sequencing
- Mucocutaneous leishmaniasis caused by Leishmania infantum in a Norwegian patient receiving TNF-α inhibitor therapy
- Epidemiology and management of HIV-2
- Metabolic dysfunction-associated steatotic liver disease in people living with HIV: a framework for integrated screening and care
- Andes virus management—balancing infection control with patient safety and autonomy
- Reimagining HIV service integration
- Funobactam for hospital-acquired pneumonia and ventilator-associated pneumonia: promising evidence, unanswered questions
- Aftershocks: Trump 2.0, Public Health, and Our Better Angels, José M Zuniga. Gatekeeper Press (2026), 534, ISBN: 9781662976346
- Imipenem–cilastatin–funobactam versus imipenem–cilastatin–relebactam in patients with hospital-acquired bacterial pneumonia or ventilator-associated bacterial pneumonia: a phase 3, double-blind, non-inferiority randomised trial
- Pharmacokinetics and safety of dolutegravir in term neonates exposed to HIV-1 (IMPAACT 2023): a phase 1, open-label, multicentre study
- South Africa's paediatric HIV tracking gap
- Fiji's national HIV emergency
- Combination antiviral treatment for a patient with lymphocytic choriomeningitis virus meningoencephalitis associated with bispecific antibody teclistamab therapy for myeloma
- Humoral immunity after mRNA SARS-CoV-2 XFG vaccination
- Ganaplacide plus lumefantrine solid dispersion formulation for children with uncomplicated Plasmodium falciparum malaria (KALUMI): an open-label, multicentre, randomised, controlled, adaptive, phase 2, non-inferiority trial
- Maternal and perinatal outcomes in pregnant women with Lassa fever: analysis from the LASCOPE prospective cohort study
- Correction to Lancet Infect Dis 2026; 26: 1010–21
- Expanding access to lenacapavir in low-income and middle-income countries